HK1257400A1 - 用於治療疾病的唑來膦酸或相關化合物的經口施用組合物 - Google Patents

用於治療疾病的唑來膦酸或相關化合物的經口施用組合物

Info

Publication number
HK1257400A1
HK1257400A1 HK18116608.0A HK18116608A HK1257400A1 HK 1257400 A1 HK1257400 A1 HK 1257400A1 HK 18116608 A HK18116608 A HK 18116608A HK 1257400 A1 HK1257400 A1 HK 1257400A1
Authority
HK
Hong Kong
Prior art keywords
compositions
oral administration
related compounds
zoledronic acid
treating disease
Prior art date
Application number
HK18116608.0A
Other languages
English (en)
Chinese (zh)
Inventor
Herriot Tabuteau
Original Assignee
安泰賽普生物風投二代有限責任公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/063,979 external-priority patent/US8802658B2/en
Application filed by 安泰賽普生物風投二代有限責任公司 filed Critical 安泰賽普生物風投二代有限責任公司
Publication of HK1257400A1 publication Critical patent/HK1257400A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK18116608.0A 2013-10-25 2018-12-26 用於治療疾病的唑來膦酸或相關化合物的經口施用組合物 HK1257400A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14/063,979 US8802658B2 (en) 2012-05-14 2013-10-25 Compositions for oral administration of zoledronic acid or related compounds for treating disease
US14/279,241 US20140249317A1 (en) 2012-05-14 2014-05-15 Compositions for oral administration of zoledronic acid or related compounds for treating disease

Publications (1)

Publication Number Publication Date
HK1257400A1 true HK1257400A1 (zh) 2019-10-18

Family

ID=52993341

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18116608.0A HK1257400A1 (zh) 2013-10-25 2018-12-26 用於治療疾病的唑來膦酸或相關化合物的經口施用組合物

Country Status (12)

Country Link
EP (1) EP3060220A4 (ko)
JP (6) JP6166471B2 (ko)
KR (3) KR101975687B1 (ko)
CN (2) CN108434154A (ko)
AU (2) AU2014340649C1 (ko)
CA (1) CA2928350C (ko)
HK (1) HK1257400A1 (ko)
IL (2) IL245287A0 (ko)
MX (1) MX2016005396A (ko)
MY (1) MY176246A (ko)
SG (3) SG10201609548UA (ko)
WO (1) WO2015060924A1 (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9999629B2 (en) 2012-05-14 2018-06-19 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US10413560B2 (en) 2012-05-14 2019-09-17 Antecip Bioventures Ii Llc Dosage forms for oral administration of zoledronic acid or related compounds for treating disease
US9956238B2 (en) 2014-05-15 2018-05-01 Antecip Bioventures Ii Llc Compositions for administration of zoledronic acid or related compounds for treating low back pain
US10016445B2 (en) 2012-05-14 2018-07-10 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome
US10493085B2 (en) 2012-05-14 2019-12-03 Antecip Bioventures Ii Llc Neridronic acid and other bisphosphonates for treating complex regional pain syndrome and other diseases
US11654152B2 (en) 2012-05-14 2023-05-23 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating disease
US10413561B2 (en) 2012-05-14 2019-09-17 Antecip Bioventures Ii Llc Neridronic acid and other bisphosphonates for treating complex regional pain syndrome and other diseases
US10463682B2 (en) 2012-05-14 2019-11-05 Antecip Bioventures Ii Llc Compositions for oral administration of zoledronic acid or related compounds for treating low back pain
US10350227B2 (en) 2012-05-14 2019-07-16 Antecip Bioventures Ii Llc Neridronic acid for treating complex regional pain syndrome
CN108434154A (zh) * 2013-10-25 2018-08-24 安泰赛普生物风投二代有限责任公司 用于治疗疾病的唑来膦酸或相关化合物的经口施用组合物
CN109891021B (zh) 2016-10-28 2022-04-12 三菱化学株式会社 碳纤维用上浆剂、碳纤维用上浆剂的水分散液、和附着有上浆剂的碳纤维束

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2321864A1 (en) * 1998-12-25 2000-07-06 Toray Industries, Inc. Interleukin-6 production inhibitor
GB0029111D0 (en) * 2000-11-29 2001-01-10 Novartis Ag Organic compounds
MXPA03010007A (es) * 2001-05-02 2004-02-12 Novartis Ag USO DE BISFOSFONATOS EN EL TRATAMIENTO DE METASTASIS DE HUESO ASOCIADO CON CANCER DE PRoSTATA.
US7875597B2 (en) * 2002-07-24 2011-01-25 New York University Treatment of spinal mechanical pain
AU2003280373A1 (en) * 2002-10-15 2004-05-04 Novartis Ag Method of administering bisphosphonates
EP1567533B1 (en) * 2003-07-03 2009-03-11 Teva Pharmaceutical Industries Ltd. Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation
AR046773A1 (es) * 2003-12-23 2005-12-21 Novartis Ag Formulaciones farmaceuticas de bisfosfonatos
HUE034784T2 (en) * 2009-07-31 2018-02-28 Gruenenthal Gmbh Crystallization process and bioavailability
LT2531200T (lt) * 2010-02-06 2017-09-25 Grünenthal GmbH Kristalizacijos būdas ir bioprieinamumas
WO2012071517A2 (en) * 2010-11-24 2012-05-31 Thar Pharmaceuticals, Inc. Novel crystalline forms
AU2013262995B2 (en) * 2012-05-14 2016-09-01 Antecip Bioventures Ii Llc Compositions comprising zoledronic acid or related compounds for relieving inflammatory pain and related conditions
CN108434154A (zh) * 2013-10-25 2018-08-24 安泰赛普生物风投二代有限责任公司 用于治疗疾病的唑来膦酸或相关化合物的经口施用组合物

Also Published As

Publication number Publication date
IL245287A0 (en) 2016-06-30
KR20170058444A (ko) 2017-05-26
JP2017200941A (ja) 2017-11-09
JP2024040304A (ja) 2024-03-25
CN105960240B (zh) 2018-04-20
JP6453387B2 (ja) 2019-01-16
EP3060220A4 (en) 2017-05-31
IL254123A0 (en) 2017-10-31
JP7136487B2 (ja) 2022-09-13
WO2015060924A1 (en) 2015-04-30
AU2014340649B2 (en) 2016-11-17
SG10201609548UA (en) 2016-12-29
AU2014340649C1 (en) 2017-05-18
EP3060220A1 (en) 2016-08-31
CA2928350A1 (en) 2015-04-30
SG11201603042TA (en) 2016-05-30
KR20160062177A (ko) 2016-06-01
MX2016005396A (es) 2017-03-01
JP2022162105A (ja) 2022-10-21
CN108434154A (zh) 2018-08-24
JP2016534081A (ja) 2016-11-04
JP6166471B2 (ja) 2017-07-19
KR101975687B1 (ko) 2019-05-07
SG10201800001VA (en) 2018-02-27
CA2928350C (en) 2018-01-09
JP2019059771A (ja) 2019-04-18
KR101739244B1 (ko) 2017-05-23
MY176246A (en) 2020-07-24
KR20190009428A (ko) 2019-01-28
AU2017200832A1 (en) 2017-03-02
CN105960240A (zh) 2016-09-21
JP2021028343A (ja) 2021-02-25
JP6802245B2 (ja) 2020-12-16

Similar Documents

Publication Publication Date Title
HK1257400A1 (zh) 用於治療疾病的唑來膦酸或相關化合物的經口施用組合物
IL241264A0 (en) Compounds and compositions for the treatment of parasitic diseases
EP2872151A4 (en) ACELLULAR PRO-TOLEROGENIC COMPOSITIONS FOR THE TREATMENT OR PREVENTION OF AUTOIMMUNE DISEASES
LT2925757T (lt) Junginiai ir kompozicijos, skirti parazitinių ligų gydymui
HK1217443A1 (zh) 用於糖尿病的口服治療的藥物組合物
EP2968321A4 (en) COMPOUNDS FOR THE TREATMENT OF FIBROSIS DISEASES
HRP20190349T1 (hr) Oralni pripravci za liječenje gastroezofagealne refluksne bolesti
PT3524260T (pt) Composições farmacêuticas para o tratamento de inapetência
HK1215794A1 (zh) 用於治療疾病的同種異體自噬體富集組合物
HUE037179T2 (hu) Gyógyászati kompozíciók izom-rendellenességek kezelésére
IL238592B (en) Compounds for the treatment of liver diseases
ZA201508452B (en) Oral formulation for the treatment of cardiovascular diseases
IL234796B (en) Compounds for the treatment of diseases related to ischemia-reperfusion
HUE037176T2 (hu) Olaj-alapú gyógyszerészeti készítmény gasztrointesztinális betegségek kezelésére
EP2854539A4 (en) PHOSPHONATE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE
GB201407847D0 (en) Composition for the oral delivery of compounds
IL240119A0 (en) Pharmaceutical compositions for oral treatment of diabetes